Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Sep 26, 2023; 11(27): 6631-6639
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6631
Figure 3
Figure 3 Magnetic resonance imaging scans acquired after one month of cessation of gonadotropin-releasing hormone agonist therapy. A: In the coronal plane, the lesion displays a subtle elevation in signal intensity on T2-weighted imaging, characterized by diffuse and homogenous fine septal modifications internally (orange arrow); B and C: In the sagittal and axial enhanced scans, the lesion demonstrates a slightly higher enhancement in both the margins and internal septations (orange arrow); D The lesion exhibits a slight increase in the diffusion-weighted imaging signal (orange arrow).